Kaabi, Nawal Al http://orcid.org/0000-0003-2180-4158
Yang, Yun Kai
Liang, Yu
Xu, Ke
Zhang, Xue Feng
Kang, Yun
Jin, Yu Qin
Hou, Jun Wei
Zhang, Jing
Yang, Tian
Hussein, Salah
ElDein, Mohamed Saif
Lei, Ze Hua
Zhang, Hao
Shao, Shuai
Liu, Zhao Ming
Liu, Ning
Zheng, Xiang
Su, Ji Guo
Yang, Sen Sen
Cong, Xiangfeng
Tan, Yao
Lei, Wenwen
Gao, Xue Jun
Jiang, Zhiwei
Wang, Hui
Li, Meng
Mekki, Hanadi Mekki
Zaher, Walid http://orcid.org/0000-0002-5868-7568
Mahmoud, Sally http://orcid.org/0000-0003-1348-9063
Zhang, Xue
Qu, Chang
Liu, Dan Ying
Zhang, Jing
Yang, Mengjie
Eltantawy, Islam
Xiao, Peng
Shen, Fu Jie
Wu, Jin Juan
Han, Zi Bo
Du, Li Fang
Tang, Fang
Chen, Shi
Ma, Zhi Jing
Zheng, Fan
Hou, Ya Nan
Li, Xin Yu
Li, Xin
Wang, Zhao Nian
Yin, Jin Liang
Mao, Xiao Yan
Zhang, Jin
Qu, Liang
Zhang, Yun Tao
Yang, Xiao Ming http://orcid.org/0000-0002-2598-4355
Wu, Guizhen
Li, Qi Ming http://orcid.org/0000-0001-8284-7106
Funding for this research was provided by:
Lanzhou Institute of Biological Products Co., Ltd (LIBP) of Sinopharm, and Beijing Institute of Biological Products Co., Ltd (BIBP) of Sinopharm
Article History
Received: 14 September 2022
Revised: 6 December 2022
Accepted: 13 December 2022
First Online: 3 January 2023
Competing interests
: Y.K.Y., T.Y., M.L., X.Zhang, C.Q., D.Y.L., Z.N.W., J.L.Y., L.Q., Y.T.Z., and X.M.Y. are employed by the China National Biotec Group Company Limited. Y.L., X.F.Z., Y.K., Y.Q.J., J.W.H., JingZ.(NVSI), Z.H.L., H.Z., S.S., Z.M.L., N.L., X.Zheng, J.G.S., S.S.Y., X.F.C., Y.T., F.J.S., J.J.W., Z.B.H., L.F.D., F.T., S.C., Z.J.M., F.Z., Y.N.H., X.Y.L., X.L., and Q.M.L. are employed by the National Vaccine and Serum Institute (NVSI). X.J.G. and X.Y.M. are employed by Lanzhou Institute of Biological Products Company Limited (LIBP). H.W. and JinZ. are employed by Beijing Institute of Biological Products Company Limited (BIBP). Q.M.L., JingZ.(NVSI), Y.L., J.G.S., L.F.D., F.T., S.S., X.F.Z., Z.H.L., Z.M.L., Z.B.H., N.L., Y.Q.J., H.Z., J.W.H., Y.N.H., Z.J.M., S.C., F.Z., and F.J.S. are listed as inventors of the patent application for NVSI-06-09 vaccine (Application number: 202210083654.X). The other authors declare no competing interests.